CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
6.65
-0.05 (-0.78%)
Nov 18, 2025, 4:00 PM EST - Market closed
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $3.82 million as of November 18, 2025. Its market cap has decreased by -30.96% in one year.
Market Cap
3.82M
Enterprise Value
-6.04M
1-Year Change
-30.96%
Ranking
Category
Stock Price
$6.65
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $3.82M, a decrease of -94.54%. That is a compound annual growth rate of -38.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 3.85M | -44.38% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | 40.05M | -37.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 916.39B |
| Johnson & Johnson | 476.20B |
| AbbVie | 414.10B |
| UnitedHealth Group | 294.10B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 231.23B |
| Abbott Laboratories | 227.34B |